[Diagnostic Significance of Muscle Biopsies in Metabolic Myopathies. I. Myopathology]

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1984 Jul 2

PMID 6592394

Authors

D Pongratz

G Hubner

T Deufel

I Paetzke

O H Wieland

Affiliations

Soon will be listed here.

Abstract

The clinical course of metabolic myopathies is dominated by progressive muscle weakness and wasting or aching contraction and recurrent rhabdomyolysis with intense exercise. Vacuolar muscle fibre degeneration is the leading pathological finding on routine histological examination. For further characterization of those histologically empty looking vacuoles, histochemistry and electron microscopy are employed. Increase of glycogen, lipid droplets or mitochondria can often be demonstrated and indicate the need for subsequent biochemical identification of the underlying metabolic defect. Some other metabolic myopathies that cause recurrent rhabdomyolysis lack myopathological abnormalities. These can only be diagnosed biochemically, but additional new histochemical screening methods might be helpful.

References

Tarui S, Okuno G, Ikura Y, Tanaka T, Suda M, Nishikawa M . PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS. Biochem Biophys Res Commun. 1965; 19:517-23. DOI: 10.1016/0006-291x(65)90156-7. View

Pongratz D, Hubner G, Deufel T, Wieland O, PONGRATZ E, Liphardt R . [Clinical, morphological and biochemical studies on muscle carnitine deficiency (author's transl)]. Klin Wochenschr. 1979; 57(18):927-36. DOI: 10.1007/BF01478549. View

Di Mauro S, Trevisan C, Hays A . Disorders of lipid metabolism in muscle. Muscle Nerve. 1980; 3(5):369-88. DOI: 10.1002/mus.880030502. View

McArdle B . Myopathy due to a defect in muscle glycogen breakdown. Clin Sci. 2014; 10(1):13-35. View

Karpati G, Carpenter S, Engel A, Watters G, Allen J, Rothman S . The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology. 1975; 25(1):16-24. DOI: 10.1212/wnl.25.1.16. View

Engel A, Angelini C . Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science. 1973; 179(4076):899-902. DOI: 10.1126/science.179.4076.899. View

Andersen D . Familial cirrhosis of the liver with storage of abnormal glycogen. Lab Invest. 1956; 5(1):11-20. View

Di Donato S, Cornelio F, Balestrini M, Bertagnolio B, Peluchetti D . Mitochondria-lipid-glycogen myopathy, hyperlactacidemia, and carnitine deficiency. Neurology. 1978; 28(11):1110-6. DOI: 10.1212/wnl.28.11.1110. View

SHY G, Gonatas N, Perez M . Two childhood myopathies with abnormal mitochondria. I. Megaconial myopathy. II. Pleoconial myopathy. Brain. 1966; 89(1):133-58. DOI: 10.1093/brain/89.1.133. View

10.

Engel A, Gomez M, Seybold M, LAMBERT E . The spectrum and diagnosis of acid maltase deficiency. Neurology. 1973; 23(1):95-106. DOI: 10.1212/wnl.23.1.95. View

11.

Pongratz D, Hubner G, Deufel T, Wieland O . [Mitigated adult forms of acid maltase deficiency (Pompe's disease). Morphologic and pathobiochemical studies]. Klin Wochenschr. 1983; 61(15):743-50. DOI: 10.1007/BF01497401. View

12.

Olson W, Engel W, Walsh G, EINAUGLER R . Oculocraniosomatic neuromuscular disease with "ragged-red" fibers. Arch Neurol. 1972; 26(3):193-211. DOI: 10.1001/archneur.1972.00490090019001. View

13.

HERS H . GLYCOGEN STORAGE DISEASE. Adv Metab Disord. 1964; 13:1-44. DOI: 10.1016/b978-1-4831-6748-0.50006-9. View

14.

FORBES G . Glycogen storage disease; report of a case with abnormal glycogen structure in liver and skeletal muscle. J Pediatr. 1953; 42(6):645-53. DOI: 10.1016/s0022-3476(53)80420-8. View

15.

Pongratz D, Schaub J, Koppenwallner C, Hubner G . [Morphological and biochemical studies on glycogenosis type V (McArdle) (author's transl)]. Klin Wochenschr. 1981; 59(18):1053-9. DOI: 10.1007/BF01747748. View